Revenue has demonstrated substantial growth over recent years, with 2026 quarterly sales notably improving versus 2025. However, operating income and EBITDA margins have shown inconsistency, including a steep operating loss in Q3 2025, reflecting uneven expense control and possibly investment hikes or extraordinary items.

The company’s revenues rose from approximately $1.36 billion in 2024 to over $2.5 billion in fiscal 2025, driven by robust consumer demand and expanded distribution. Q1 and Q2 of 2026 continued this trend with quarter-over-quarter growth, suggesting underlying demand strength.

Gross margins have clustered around the high 40% to low 50% range, indicative of solid product pricing and cost structure. However, operating margins have been more volatile, impacted by fluctuating SG&A expenses and other costs, leading to net margins around 4-17% in profitable quarters, but negative in others.

Earnings quality appears mixed due to variations in non-operating expenses and interest costs, alongside periodic impairments or other charges. The substantial swings in net income and diluted EPS reflect both operational challenges and episodic non-operating effects, requiring cautious interpretation.

Year-over-year revenue grew markedly from $1.36 billion in 2024 to $2.52 billion in 2025, representing an 85.8% increase. Sequentially, quarterly revenues increased about 4.5% from Q1 to Q2 2026 and by roughly 4.5% from Q2 to Q3 2026, demonstrating ongoing momentum.

Earnings per share showed volatility; EPS peaked around $0.47 in Q2 2025 and dipped as low as -$0.30 in Q3 2025 but recovered to $0.36 by Q2 2026. Overall, EPS has trended upward despite temporary profit setbacks.

Growth is driven primarily by expanded consumer adoption of functional energy beverages, geographic expansion, and penetrative marketing efforts. The brand’s alignment with health trends fuels demand sustainability.

Much of the growth appears organic, supported by core product demand and distribution gains rather than acquisitions. However, margin pressures raise questions about scalability without efficiency improvements.

Gross margins have remained stable near 48-52%, reflecting consistent product pricing and cost management. Operating margins experienced volatility, from positive expansions to sharp negative swings, notably Q3 2025’s operating loss of over 11%. Net margins similarly fluctuated between 20% and negative levels in recent quarters.

Return on equity and assets metrics are not provided, but net income ratios suggest returns are currently under pressure from expense volatility and interest costs.

Sustaining stable margins requires controlled SG&A growth and optimization of cost structure. Current volatility suggests the need for operational discipline to underpin profitability over the long term.